PAVLOVSKA, Iuliia, J. I. MECHANICK, G. A. M. NETO, M. M. INFANTE-GARCIA, R. NIETO-MARTINEZ, Šárka KUNZOVÁ, Anna POLCROVÁ, Robert VYSOKÝ, J. R. MEDINA-INOJOSA, F. LOPEZ-JIMENEZ, G. B. STOKIN a J. P. GONZALEZ-RIVAS. Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study. Endocrine Practice. Jacksonville: American Association of Clinical Endocrinology, 2021, roč. 27, č. 6, s. 571-578. ISSN 1530-891X. Dostupné z: https://dx.doi.org/10.1016/j.eprac.2021.03.004.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Arterial Stiffness and Cardiometabolic-Based Chronic Disease: The Kardiovize Study
Autoři PAVLOVSKA, Iuliia (804 Ukrajina, garant, domácí), J. I. MECHANICK, G. A. M. NETO, M. M. INFANTE-GARCIA, R. NIETO-MARTINEZ, Šárka KUNZOVÁ (203 Česká republika), Anna POLCROVÁ (203 Česká republika, domácí), Robert VYSOKÝ (203 Česká republika, domácí), J. R. MEDINA-INOJOSA, F. LOPEZ-JIMENEZ, G. B. STOKIN a J. P. GONZALEZ-RIVAS.
Vydání Endocrine Practice, Jacksonville, American Association of Clinical Endocrinology, 2021, 1530-891X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30202 Endocrinology and metabolism
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.701
Kód RIV RIV/00216224:14110/21:00121969
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.eprac.2021.03.004
UT WoS 000670046400007
Klíčová slova anglicky adiposity; atherosclerosis; cardio-ankle vascular index; diabetes; obesity; type 2 diabetes
Štítky 14110525, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 17. 5. 2022 10:20.
Anotace
Objective: Arterial stiffness (ArSt) describes a loss of arterial wall elasticity and is an independent predictor of cardiovascular events. A cardiometabolic-based chronic disease model integrates concepts of adiposity-based chronic disease (ABCD), dysglycemia-based chronic disease (DBCD), and cardiovascular disease. We assessed if ABCD and DBCD models detect more people with high ArSt compared with traditional adiposity and dysglycemia classifiers using the cardio-ankle vascular index (CAVI). Methods: We evaluated 2070 subjects aged 25 to 64 years from a random population-based sample. Those with type 1 diabetes were excluded. ABCD and DBCD were defined, and ArSt risk was stratified based on the American Association of Clinical Endocrinologists criteria. Results: The highest prevalence of a high CAVI was in stage 2 ABCD (18.5%) and stage 4 DBCD (31.8%), and the lowest prevalence was in stage 0 ABCD (2.2%). In univariate analysis, stage 2 ABCD and all DBCD stages increased the risk of having a high CAVI compared with traditional classifiers. After adjusting for age and gender, only an inverse association between obesity (body mass index >= 30 kg/m(2)) and CAVI remained significant. Nevertheless, body mass index was responsible for only 0.3% of CAVI variability. Conclusion: The ABCD and DBCD models showed better performance than traditional classifiers to detect subjects with ArSt; however, the variables were not independently associated with age and gender, which might be explained by the complexity and multifactoriality of the relationship of CAVI with the ABCD and DBCD models, mediated by insulin resistance. (C) 2021 AACE. Published by Elsevier Inc. All rights reserved.
VytisknoutZobrazeno: 9. 10. 2024 05:27